BESSEMER GROUP INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 241 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,813
+37750.0%
148,144
+46195.0%
0.02%
Q2 2023$18
+260.0%
320
+131.9%
0.00%
Q1 2023$5
+66.7%
138
+21.1%
0.00%
Q4 2022$3
-99.9%
1140.0%0.00%
Q3 2022$3,000
-50.0%
114
-29.6%
0.00%
Q2 2022$6,0000.0%1620.0%0.00%
Q1 2022$6,000
-99.8%
162
-99.9%
0.00%
-100.0%
Q2 2020$2,507,000
+51.4%
111,6000.0%0.01%
+14.3%
Q1 2020$1,656,000
-22.4%
111,600
+0.8%
0.01%0.0%
Q4 2019$2,135,000
+2.4%
110,700
+5.3%
0.01%0.0%
Q3 2019$2,084,000
+0.2%
105,100
+6.7%
0.01%0.0%
Q2 2019$2,079,000
+1.9%
98,500
-1.4%
0.01%
-12.5%
Q1 2019$2,041,000
+45.5%
99,900
+41.7%
0.01%
+33.3%
Q4 2018$1,403,000
+126.3%
70,500
+118.9%
0.01%
+200.0%
Q3 2018$620,000
+248.3%
32,200
+242.6%
0.00%
+100.0%
Q3 2016$178,0009,4000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders